Nonetheless, Safestore raised its final dividend per share to 20.40p from 20.20p the previous year, subject to approval at March 19's annual meeting. "We have delivered resilient operating performance ...
(Alliance News) - Brooks Macdonald Group PLC said it plans to move to the London Stock Exchange Main Market by March. The London-based wealth manager said admission to the Main Market would "further ...
London's stock markets closed significantly higher on Wednesday, buoyed by positive inflation data from both sides of the Atlantic. The FTSE 100 index climbed 1.21% to 8,301.13 points, while the FTSE ...
(Alliance News) - Advanced Medical Solutions Group PLC shares surged on Tuesday as it gave a positive update and said it performed in line with consensus expectations in 2024.
Separate from the placing, during November and December 2024, said its indirect subsidiary, Reinet Jersey Holdings Ltd, sold 5 million BAT shares through a "dribble-out" process on the London Stock ...
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Eden Research PLC - Oxfordshire, England-based developer of ...
(Alliance News) - Orosur Mining Inc on Monday reported "exceptional results" from three more holes at the Anza gold project in Colombia.
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.
While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...
In contrast to the gloomy mood in Europe, US markets pushed higher. At the time of the London close, the Dow Jones Industrial Average was up 0.6%, the S&P 500 was 1.0% higher and the Nasdaq Composite ...
(Alliance News) - Jubilee Metals Group PLC on Monday reported its copper production fell short of guidance for the first half of its financial year as the company grappled with electricity outages in ...
(Alliance News) - PureTech Health PLC on Thursday said that the US Food & Drug Administration has granted fast track designation to its antibody LYT-200 for the treatment of acute myeloid leukemia.